4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-22-004488
President and Chief Executive acquired 41,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curran Terrie President and Chief Executive | 2022-01-19 | Grant or award | +41,250 | 44,095 | D | ||
| Derivatives | |||||||
| Curran Terrie President and Chief Executive | 2022-01-19 | Grant or award · Stock Option (Right to Buy) | +206,250 | 206,250 | D | ||
Loading xslF345X03/doc4.xml…